(NEXSTAR) – That small whoosh from an inhaler has a substantial environmental toll that could be putting some people with chronic conditions at risk, according to a new study. Published Monday in the ...

In the months following Elon Musk’s $44 billion acquisition of Twitter in 2022, my experience with the platform (and perhaps yours too) got quickly, dramatically worse. My algorithmic timeline, better ...

I started voice lessons last May in an effort to stop blowing my voice out every time I belted Creed’s “One Last Breath” at karaoke. I’ve made strides since then — moving on from Scott Stapp to David ...

Add Yahoo as a preferred source to see more of our stories on Google. A major pharmaceutical company ended price hikes and monopoly protection over a life-saving asthma inhaler following two years of ...

In a statement Monday, GSK said it supported Prasco’s decision to offer free inhalers to eligible patients and has launched its own program to cap the out-of-pocket monthly cost for any of its nine ...

Researchers conducted an observational study using real‑world data to compare the effectiveness and safety of initiating three fixed‑dose long‑acting muscarinic antagonist (LAMA)-long‑acting beta‑2 ...

Research has found that children using 6 or more blue reliever inhalers a year are 3-5 times more likely to have an asthma attack. Reliever inhalers only treat the immediate symptoms and mask the ...

Glaxo Smith Kline’s decision to discontinue a popular children’s asthma inhaler, Flovent, more than two years ago has caused disruptions for physicians and health consequences for families nationwide, ...

Inhaled corticosteroid–long-acting beta-agonist (ICS-LABA) inhalers are widely prescribed for asthma and chronic obstructive pulmonary disease. ICS-LABAs are largely interchangeable within the class; ...

The FDA has approved a generic version of fluticasone propionate (marketed as Flovent HFA), according to a statement issued on March 3. The approval extends the accessibility of the medication, ...

The White House’s direct-to-consumer (DTC) platform, TrumpRx, is steadily expanding its catalogue, with products from GSK and Amgen the latest to join the collection of drugs offered through the ...